Healthcare provider profile · identity verified

Desi Canals, MD

Family Practice · MISSION, TX · NPI 1851460695

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	231	74
Metformin Hcl	Metformin Hcl	154	47
Losartan Potassium	Losartan Potassium	149	41
Levothyroxine Sodium	Levothyroxine Sodium	142	41
Shingrix	Varicella-Zoster Ge/As01b/Pf	128	100
Omeprazole	Omeprazole	111	35
Ibuprofen	Ibuprofen	105	55
Hydrochlorothiazide	Hydrochlorothiazide	97	18
Pantoprazole Sodium	Pantoprazole Sodium	97	30
Tamsulosin Hcl	Tamsulosin Hcl	88	23
Lisinopril	Lisinopril	87	27
Rosuvastatin Calcium	Rosuvastatin Calcium	87	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	78	78
Metoprolol Succinate	Metoprolol Succinate	76	31
Montelukast Sodium	Montelukast Sodium	76	18
Amlodipine Besylate	Amlodipine Besylate	62	25
Gabapentin	Gabapentin	58	21
Azithromycin	Azithromycin	52	46
Diclofenac Sodium	Diclofenac Sodium	48	22
Meclizine Hcl	Meclizine Hcl	47	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	44	44
Donepezil Hcl	Donepezil Hcl	44	13
Sertraline Hcl	Sertraline Hcl	43	11
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Jardiance	Empagliflozin	40	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Cefdinir	Cefdinir	39	36
Metoprolol Tartrate	Metoprolol Tartrate	38	11
Olmesartan Medoxomil	Olmesartan Medoxomil	36	suppressed
Alendronate Sodium	Alendronate Sodium	33	11
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Famotidine	Famotidine	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	25
Simvastatin	Simvastatin	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Meloxicam	Meloxicam	26	14
Albuterol Sulfate Hfa	Albuterol Sulfate	23	11
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Hydrocortisone	Hydrocortisone	23	17
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Nystatin	Nystatin	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Telmisartan	Telmisartan	21	suppressed
Trazodone Hcl	Trazodone Hcl	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	19
Fluticasone Propionate	Fluticasone Propionate	20	13
Furosemide	Furosemide	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Linzess	Linaclotide	19	suppressed
Mupirocin	Mupirocin	19	15
Ozempic	Semaglutide	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Naproxen	Naproxen	18	11
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Atenolol	Atenolol	17	suppressed
Methylprednisolone	Methylprednisolone	16	13
Gemfibrozil	Gemfibrozil	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Telmisartan-Amlodipine	Telmisartan/Amlodipine	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	12
Glipizide	Glipizide	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Dexamethasone Sodium Phosphate	Dexamethasone Sodium Phosphate	12	suppressed
Finasteride	Finasteride	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error